SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001578563-24-000015
Filing Date
2024-01-12
Accepted
2024-01-12 17:46:45
Documents
2
Period of Report
2024-01-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2120
2 POA poalhoffman.txt EX-24 3771
  Complete submission text file 0001578563-24-000015.txt   7691
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O COVALENT GROUP, INC. 1275 DRUMMERS LANE, SUITE 100 WAYNE PA 19087
Business Address
HOFFMAN LAWRENCE R (Reporting) CIK: 0001211249 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34600 | Film No.: 24533068